Invention Grant
US09493432B2 Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders
有权
环戊基苯甲酰胺衍生物及其用于治疗精神病和认知障碍的用途
- Patent Title: Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders
- Patent Title (中): 环戊基苯甲酰胺衍生物及其用于治疗精神病和认知障碍的用途
-
Application No.: US15029356Application Date: 2014-10-14
-
Publication No.: US09493432B2Publication Date: 2016-11-15
- Inventor: Charlotte Fieldhouse , Angela Glen , John Stephen Robinson , Tatsuhiko Fujimoto
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceuticals Company Limited
- Current Assignee: Takeda Pharmaceuticals Company Limited
- Current Assignee Address: JP Osaka
- Agency: Barnes & Thornburg LLP
- Agent Scott D. Rothenberger
- Priority: GB1318222.5 20131015
- International Application: PCT/GB2014/053079 WO 20141014
- International Announcement: WO2015/055994 WO 20150423
- Main IPC: C07D277/82
- IPC: C07D277/82 ; C07D241/44 ; C07D401/12 ; C07D263/58 ; C07D413/12 ; C07D417/14 ; C07D417/12 ; C07D277/64 ; C07D403/12 ; C07D215/12 ; C07D513/04
Abstract:
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein n, L, X, Ra, Rb, R1, R2 and R3 their preparation, pharmaceutical compositions containing them and their use in therapy.
Public/Granted literature
- US20160222030A1 Cyclopentylbenzamide Derivatives and their Use for the Treatment of Psychotic and Cognitive Disorders Public/Granted day:2016-08-04
Information query
